BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 18653238)

  • 1. Improving platinum(II)-based anticancer drug delivery using cucurbit[n]urils.
    Wheate NJ
    J Inorg Biochem; 2008 Dec; 102(12):2060-6. PubMed ID: 18653238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Encapsulation of platinum(II)-based DNA intercalators within cucurbit[6,7,8]urils.
    Kemp S; Wheate NJ; Wang S; Collins JG; Ralph SF; Day AI; Higgins VJ; Aldrich-Wright JR
    J Biol Inorg Chem; 2007 Sep; 12(7):969-79. PubMed ID: 17653578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Degradation of bidentate-coordinated platinum(II)-based DNA intercalators by reduced L-glutathione.
    Kemp S; Wheate NJ; Pisani MJ; Aldrich-Wright JR
    J Med Chem; 2008 May; 51(9):2787-94. PubMed ID: 18412325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxicology and drug delivery by cucurbit[n]uril type molecular containers.
    Hettiarachchi G; Nguyen D; Wu J; Lucas D; Ma D; Isaacs L; Briken V
    PLoS One; 2010 May; 5(5):e10514. PubMed ID: 20463906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cucurbit[n]uril binding of platinum anticancer complexes.
    Wheate NJ; Buck DP; Day AI; Collins JG
    Dalton Trans; 2006 Jan; (3):451-8. PubMed ID: 16395444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxicity of cucurbit[7]uril and cucurbit[8]uril: an exploratory in vitro and in vivo study.
    Uzunova VD; Cullinane C; Brix K; Nau WM; Day AI
    Org Biomol Chem; 2010 May; 8(9):2037-42. PubMed ID: 20401379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Interaction of cucurbit[ n ]urils and quinoline or its derivatives].
    Du Y; Xue SF; Mu L; Zhu QJ; Tao Z; Zhang JX
    Guang Pu Xue Yu Guang Pu Fen Xi; 2005 Aug; 25(8):1281-5. PubMed ID: 16329501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Supramolecular Chemotherapy with Cucurbit[
    Shukla S; Sagar B; Sood AK; Gaur A; Batra S; Gulati S
    ACS Appl Bio Mater; 2023 Jun; 6(6):2089-2101. PubMed ID: 37224296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization and cellular uptake of platinum anticancer drugs encapsulated in apoferritin.
    Xing R; Wang X; Zhang C; Zhang Y; Wang Q; Yang Z; Guo Z
    J Inorg Biochem; 2009 Jul; 103(7):1039-44. PubMed ID: 19501911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photodeamination to quinone methides in cucurbit[n]urils: potential application in drug delivery.
    Škalamera Đ; Matković M; Uzelac L; Kralj M; Mlinarić-Majerski K; Bohne C; Basarić N
    Org Biomol Chem; 2018 Nov; 16(46):8908-8912. PubMed ID: 30422137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inclusion complexes of the antitumour metallocenes Cp(2)MCl(2) (M = Mo, Ti) with cucurbit[n]urils.
    Buck DP; Abeysinghe PM; Cullinane C; Day AI; Collins JG; Harding MM
    Dalton Trans; 2008 May; (17):2328-34. PubMed ID: 18414758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-nuclear platinum complexes encapsulated in cucurbit[n]uril as an approach to reduce toxicity in cancer treatment.
    Wheate NJ; Day AI; Blanch RJ; Arnold AP; Cullinane C; Collins JG
    Chem Commun (Camb); 2004 Jun; (12):1424-5. PubMed ID: 15179496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanism for the encapsulation of the doxorubicin in the cucurbit[n]urils cavity and the effects of diameter, protonation on loading and releasing of the anticancer drug:Mixed quantum mechanical/ molecular dynamics simulations.
    Hasanzade Z; Raissi H
    Comput Methods Programs Biomed; 2020 Nov; 196():105563. PubMed ID: 32531653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microwave synthesis of cucurbit[n]urils.
    Wheate NJ; Patel N; Sutcliffe OB
    Future Med Chem; 2010 Feb; 2(2):231-6. PubMed ID: 21426190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chirality sensing of terpenes, steroids, amino acids, peptides and drugs with acyclic cucurbit[n]urils and molecular tweezers.
    Prabodh A; Bauer D; Kubik S; Rebmann P; Klärner FG; Schrader T; Delarue Bizzini L; Mayor M; Biedermann F
    Chem Commun (Camb); 2020 Apr; 56(34):4652-4655. PubMed ID: 32253396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel molecular drug carrier: encapsulation of oxaliplatin in cucurbit[7]uril and its effects on stability and reactivity of the drug.
    Jeon YJ; Kim SY; Ko YH; Sakamoto S; Yamaguchi K; Kim K
    Org Biomol Chem; 2005 Jun; 3(11):2122-5. PubMed ID: 15917899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in platinum chemotherapeutics.
    Harper BW; Krause-Heuer AM; Grant MP; Manohar M; Garbutcheon-Singh KB; Aldrich-Wright JR
    Chemistry; 2010 Jun; 16(24):7064-77. PubMed ID: 20533453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanomolar Binding of Steroids to Cucurbit[n]urils: Selectivity and Applications.
    Lazar AI; Biedermann F; Mustafina KR; Assaf KI; Hennig A; Nau WM
    J Am Chem Soc; 2016 Oct; 138(39):13022-13029. PubMed ID: 27673427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The state-of-play and future of platinum drugs.
    Apps MG; Choi EH; Wheate NJ
    Endocr Relat Cancer; 2015 Aug; 22(4):R219-33. PubMed ID: 26113607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Side-on binding of p-sulphonatocalix[4]arene to the dinuclear platinum complex trans-[{PtCl(NH3)2}2mu-dpzm]2+ and its implications for anticancer drug delivery.
    Wheate NJ; Abbott GM; Tate RJ; Clements CJ; Edrada-Ebel R; Johnston BF
    J Inorg Biochem; 2009 Mar; 103(3):448-54. PubMed ID: 19171382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.